Sohaib Mir
Directeur/Membre du Conseil chez Montis Biosciences BV
Profil
Sohaib Mir joined LifeArc as Senior Investment Principal at LifeArc Ventures in 2021.
He is responsible for leading new investments and managing existing portfolio companies.
Sohaib brings more than 10 years of experience across investment banking and venture capital following a career in medicine.
He was an Investment Director with ALSA Ventures, focused on therapeutics investing, a Principal at Cambridge Innovation Capital and worked in healthcare M&A with Perella Weinberg Partners.
Sohaib qualified in Medicine at the University of Birmingham where he also completed a PhD in CNS regeneration.
He practised medicine at Addenbrooke’s Hospital in Cambridge and gained an MPhil in Bioscience Enterprise from the University of Cambridge.
Postes actifs de Sohaib Mir
| Sociétés | Poste | Début |
|---|---|---|
Montis Biosciences BV
 Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Directeur/Membre du Conseil | 01/12/2019 |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Directeur/Membre du Conseil | 05/12/2022 |
Lifearc Ventures
 Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 10/10/2021 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Directeur/Membre du Conseil | 21/09/2023 |
Anciens postes connus de Sohaib Mir
| Sociétés | Poste | Fin |
|---|---|---|
Alsa Management Services Ltd
 Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/10/2021 |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Analyste en capital-investissement | 01/09/2019 |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 20/08/2019 |
| PERELLA WEINBERG PARTNERS | Corporate Officer/Principal | 01/06/2014 |
Formation de Sohaib Mir
| University of Cambridge | Graduate Degree |
| University of Birmingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PERELLA WEINBERG PARTNERS | Finance |
| Entreprise privées | 7 |
|---|---|
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Finance |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Health Technology |
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Finance |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | Finance |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Health Technology |
